These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12183116)

  • 1. Measuring drug-related receptor occupancy with positron emission tomography.
    Passchier J; Gee A; Willemsen A; Vaalburg W; van Waarde A
    Methods; 2002 Jul; 27(3):278-86. PubMed ID: 12183116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring receptor occupancy with PET.
    Waarde Av
    Curr Pharm Des; 2000 Nov; 6(16):1593-610. PubMed ID: 10974155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation of central nervous system occupancy from animal models: application of pharmacokinetic/pharmacodynamic modeling.
    Melhem M
    J Pharmacol Exp Ther; 2013 Oct; 347(1):2-6. PubMed ID: 23857976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor Occupancy Imaging Studies in Oncology Drug Development.
    Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
    AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development.
    Burns HD; Hamill TG; Eng WS; Francis B; Fioravanti C; Gibson RE
    Curr Opin Chem Biol; 1999 Aug; 3(4):388-94. PubMed ID: 10419855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-receptor interactions as studied by PET: implications for drug development.
    Hietala J
    Ann Med; 1999 Dec; 31(6):438-43. PubMed ID: 10680859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
    Okubo Y; Suhara T
    Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
    Talbot PS; Laruelle M
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.
    Cunningham VJ; Rabiner EA; Slifstein M; Laruelle M; Gunn RN
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):46-50. PubMed ID: 19738632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of the brain cannabinoid receptor.
    Gifford AN; Makriyannis A; Volkow ND; Gatley SJ
    Chem Phys Lipids; 2002 Dec; 121(1-2):65-72. PubMed ID: 12505691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating drug discovery and development through in vivo imaging.
    Eckelman WC
    Nucl Med Biol; 2002 Nov; 29(8):777-82. PubMed ID: 12453585
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioligand studies: imaging and quantitative analysis.
    Lammertsma AA
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):513-6. PubMed ID: 12468014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT and PET imaging of brain tumors.
    Hustinx R; Alavi A
    Neuroimaging Clin N Am; 1999 Nov; 9(4):751-66. PubMed ID: 10517943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography in CNS drug discovery and drug monitoring.
    Piel M; Vernaleken I; Rösch F
    J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small animal PET.
    Myers R; Hume S
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):545-55. PubMed ID: 12468017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.
    Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ
    Neuropharmacology; 1996; 35(9-10):1483-91. PubMed ID: 9014164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative PET Imaging in Drug Development: Estimation of Target Occupancy.
    Naganawa M; Gallezot JD; Rossano S; Carson RE
    Bull Math Biol; 2019 Sep; 81(9):3508-3541. PubMed ID: 29230702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.